M. Katano et al., INCREASED PROLIFERATION OF A HUMAN BREAST-CARCINOMA CELL-LINE BY RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 39(3), 1994, pp. 161-166
Two adenocarcinoma cell lines, Breast M25-SF and Breast M, were establ
ished from tumor tissue resected surgically from a patient with breast
cancer. One, Breast M25-SF, expresses interleukin-2 receptor (IL-2R)
on the cell surface and the other, Breast M, does not. The effects of
recombinant interleukin-2 (rIL-2) on the proliferation of these cell l
ines were investigated. The growth of Breast M25-SF was significantly
promoted by rIL-2 ranging from 1.25 U/ml to 640 U/ml. Anti-CD25 (Tac)
antibody significantly blocked the growth enhancement of Breast M25-SF
by rIL-2. Breast M, however, did not respond to rIL-2. To confirm mor
e directly the promotion of Breast M25-SF growth by rIL-2, cloning of
IL-2 responders from parent Breast M25-SF cells was carried out by lim
iting dilution without feeder cells in 96-well microplates. No colony
formation was found in 24 wells without rIL-2. Eleven, 13 and 6 clones
were established from groups of 24 wells containing rIL-2 at 200, 20
and 2 U/ml respectively. All of the clones expressed IL-2R and respond
to rIL-2. By using a sensitive polymerase chain reaction technique, w
e demonstrated that Breast M25-SF but not Breast M expressed IL-2 mRNA
, and IL-2 secretion from Breast M25-SF but not Breast M was also conf
irmed by radioimmunoassay. These findings suggest a role for IL-2 in a
utocrine support of Breast M25-SF growth. IL-2 may play an important r
ole in the growth control of breast carcinoma cells.